Acute Cholecystitis Following Ipilimumab and Nivolumab Treatment for Metastatic Melanoma

Abstract

Get full access to this article

View all access options for this article.

References

Snyder

Makarov

Merghoub

. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med. 2014;371(23):2189-2199. doi:10.1056/NEJMoa1406498

Weber

Mandala

Del Vecchio

. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377(19):1824-1835. doi:10.1056/NEJMoa1709030

FDA . OPDIVO (nivolumab). https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125554s078lbl.pdf. 2020. Accessed June 20, 2020.

Gelsomino

Vitale

Ardizzoni

. A case of nivolumab-related cholangitis and literature review: How to look for the right tools for a correct diagnosis of this rare immune-related adverse event. Invest New Drugs. 2018;36(1):144-146. doi:10.1007/s10637-017-0484-6